Agilent Technologies Inc. (A) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q3 26	$1.49	$1.62	+8.7%	—	$1.9B	—
Q2 26	$1.41	$1.49	+5.7%	—	$1.8B	—
Q1 26	$0.96	$1	+4.2%	—	$1.8B	—
Q4 25	$1.58	$1.59	+0.6%	—	$1.9B	—
Q3 25	$1.37	$1.37	0.0%	—	$1.7B	—
Q2 25	$1.26	$1.31	+4.0%	—	$1.7B	—
Q1 25	$1.27	$1.31	+3.1%	—	$1.7B	—
Q4 24	$1.41	$1.46	+3.5%	—	$1.7B	—
Q3 24	$1.26	$1.32	+4.8%	—	$1.6B	—
Q2 24	$1.19	$1.22	+2.5%	—	$1.6B	—
Q1 24	$1.23	$1.29	+4.9%	—	$1.7B	—
Q4 23	$1.34	$1.38	+3.0%	—	$1.7B	—
Q3 23	$1.36	$1.43	+5.1%	—	$1.7B	—
Q2 23	$1.26	$1.27	+0.8%	—	$1.7B	—
Q1 23	$1.3	$1.37	+5.4%	—	$1.8B	—
Q4 22	$1.39	$1.53	+10.1%	—	$1.8B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$4.59	—	—	$6.9B	—
FY24	—	$4.44	—	—	$6.5B	—
FY23	—	$4.22	—	—	$6.8B	—
FY22	—	$4.19	—	—	$6.8B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$4.2B	$4.5B	$4.9B	$5.2B	$5.3B	$6.3B	$6.8B	$6.8B	$6.5B	$6.9B
YoY change	+4.06%	+6.43%	+9.88%	+5.07%	+3.41%	+18.4%	+8.37%	-0.22%	-4.73%	+6.73%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	4.2B	4.5B	4.9B	5.2B	5.3B	6.3B	6.8B	6.8B	6.5B	6.9B
Cost of revenue	2B	2.1B	2.2B	2.4B	2.5B	2.9B	3.1B	3.4B	3B	3.3B
Gross profit	2.2B	2.4B	2.7B	2.8B	2.8B	3.4B	3.7B	3.5B	3.5B	3.6B
Gross margin	52.3%	53.6%	54.5%	54.3%	53.1%	53.9%	54.4%	50.7%	54.3%	52.4%
Research & development	329M	341M	387M	404M	495M	441M	467M	481M	479M	455M
Selling, general & administrative	1.3B	1.3B	1.4B	1.5B	1.5B	1.6B	1.6B	1.6B	1.6B	1.7B
Operating expenses	1.6B	1.6B	1.8B	1.9B	2B	2.1B	2.1B	2.1B	2B	2.2B
Operating income	615M	807M	904M	941M	846M	1.3B	1.6B	1.4B	1.5B	1.5B
Operating margin	14.6%	18%	18.4%	18.2%	15.8%	21.3%	23.6%	19.8%	22.9%	21.3%
Non-operating income, net	-10M	53M	79M	16M	66M	92M	-39M	33M	49M	6M
Pretax income	544M	803M	946M	919M	842M	1.4B	1.5B	1.3B	1.5B	1.4B
Income tax	82M	119M	630M	-152M	123M	150M	250M	99M	232M	132M
Net income	462M	684M	316M	1.1B	719M	1.2B	1.3B	1.2B	1.3B	1.3B
Net margin	11%	15.3%	6.43%	20.7%	13.5%	19.1%	18.3%	18.1%	19.8%	18.8%
EBITDA	862M	1.1B	1.2B	1.2B	1.2B	1.8B	1.9B	1.7B	1.9B	1.8B
EPS	1.41	2.12	0.98	3.41	2.33	3.98	4.19	4.22	4.44	4.59
Diluted EPS	1.4	2.1	0.97	3.37	2.3	3.94	4.18	4.19	4.43	4.57

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	1.7B	1.7B	1.6B	1.6B	1.7B	1.7B	1.7B	1.7B	1.9B	1.8B	1.8B	1.9B
Cost of revenue	773M	750M	717M	723M	785M	782M	802M	850M	871M	852M	845M	836M
Gross profit	915M	908M	856M	855M	916M	899M	866M	888M	990M	946M	990M	1B
Gross margin	54.2%	54.8%	54.4%	54.2%	53.9%	53.5%	51.9%	51.1%	53.2%	52.6%	54%	55.5%
Research & development	114M	128M	113M	127M	111M	113M	112M	111M	119M	117M	126M	123M
Selling, general & administrative	393M	396M	380M	395M	397M	410M	454M	417M	428M	476M	465M	475M
Operating expenses	507M	524M	493M	522M	508M	523M	566M	528M	547M	593M	591M	598M
Operating income	408M	384M	363M	333M	408M	376M	300M	360M	443M	353M	399M	444M
Operating margin	24.2%	23.2%	23.1%	21.1%	24%	22.4%	18%	20.7%	23.8%	19.6%	21.7%	23.6%
Non-operating income, net	17M	23M	12M	13M	1M	4M	-25M	18M	9M	21M	21M	14M
Pretax income	420M	403M	374M	343M	401M	367M	260M	366M	442M	364M	408M	444M
Income tax	-55M	55M	66M	61M	50M	49M	45M	30M	8M	59M	69M	82M
Net income	475M	348M	308M	282M	351M	318M	215M	336M	434M	305M	339M	362M
Net margin	28.1%	21%	19.6%	17.9%	20.6%	18.9%	12.9%	19.3%	23.3%	17%	18.5%	19.3%
EBITDA	504M	487M	457M	428M	502M	467M	362M	466M	540M	456M	500M	539M
EPS	1.63	1.19	1.05	0.97	1.23	1.12	0.75	1.18	1.53	1.08	1.2	1.28
Diluted EPS	1.62	1.18	1.05	0.97	1.22	1.11	0.75	1.18	1.53	1.07	1.2	1.28

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	14.2B	21.9B	20.8B	23.8B	31.5B	47.9B	41.4B	30.4B	37.8B	41.6B	49.4B
Enterprise value	13.8B	21.2B	20.3B	24.8B	32.5B	49B	43.1B	31.5B	39.9B	43.1B	51.1B
Shares outstanding	326M	322M	321M	314M	309M	304M	299M	294M	290M	284M	284M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	30.7	32	65.8	22.2	43.9	39.6	33	24.5	29.3	31.9	34.6
P/S	3.38	4.9	4.23	4.61	5.91	7.58	6.04	4.45	5.8	5.98	6.7
P/B	3.35	4.53	4.55	5.01	6.47	8.88	7.8	5.2	6.41	6.17	6.71
EV/EBITDA	16	19.4	16.5	20.2	26.4	27.8	22.6	18.5	21.3	23.5	24.6
EV/Sales	3.29	4.75	4.14	4.81	6.08	7.76	6.29	4.62	6.12	6.21	6.93
Earnings yield	3.25%	3.12%	1.52%	4.5%	2.28%	2.53%	3.03%	4.08%	3.41%	3.13%	2.89%
FCF yield	4.6%	3.25%	4.38%	3.64%	2.54%	2.71%	2.47%	4.85%	3.63%	2.77%	2.15%
PEG	—	—	—	—	—	—	—	—	—	—	4.09

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	52.3%	53.6%	54.5%	54.3%	53.1%	53.9%	54.4%	50.7%	54.3%	52.4%	55.5%
Operating margin	14.6%	18%	18.4%	18.2%	15.8%	21.3%	23.6%	19.8%	22.9%	21.3%	25.6%
Net margin	11%	15.3%	6.43%	20.7%	13.5%	19.1%	18.3%	18.1%	19.8%	18.8%	19.5%
ROE	10.9%	14.1%	6.91%	22.6%	14.8%	22.5%	23.6%	21.2%	21.9%	19.3%	21%
ROA	5.93%	8.12%	3.7%	11.3%	7.47%	11.3%	11.9%	11.5%	10.9%	10.2%	8.63%
ROIC	13.5%	16.5%	7.32%	16.3%	12.5%	18.3%	19.2%	17.9%	15.8%	16.2%	14.9%
Return on tangible assets	24%	27.5%	19.6%	2.1K%	94.5%	152.6%	127.2%	65.5%	71.7%	45.1%	68.7%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	3.85	3.3	3.29	1.53	2.33	2.22	2.03	2.61	2.09	1.96	2.05
Quick ratio	3.28	2.85	2.74	1.21	1.84	1.74	1.47	1.97	1.58	1.52	1.56
Debt / equity	0.45	0.42	0.39	0.51	0.48	0.51	0.52	0.47	0.57	0.5	0.56
Debt / assets	0.24	0.24	0.21	0.25	0.25	0.25	0.26	0.25	0.29	0.26	0.28
Net debt / EBITDA	-0.45	-0.61	-0.36	0.83	0.75	0.65	0.9	0.67	1.1	0.85	1.08
Interest coverage	8.56	11.2	13.6	13.4	11.8	17.8	18.9	15.1	16.8	13.8	16.6
Effective tax rate	15.1%	14.8%	66.6%	0%	14.6%	11%	16.6%	7.39%	15.3%	9.2%	13.1%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	12.9	13.9	15.3	16.4	17.3	20.8	22.9	23.2	22.4	24.5	26.1
EPS (basic)	1.41	2.12	0.98	3.41	2.33	3.98	4.19	4.22	4.44	4.59	4.59
EPS (diluted)	1.4	2.1	0.97	3.37	2.3	3.94	4.18	4.19	4.43	4.57	5.06
Book value per share	13	15	14.2	15.1	15.8	17.7	17.7	19.9	20.3	23.7	26.1
FCF per share	2.01	2.21	2.83	2.75	2.6	4.27	3.41	5.01	4.73	4.06	4.48
Cash per share	7.02	8.32	7	4.4	4.66	5.18	3.52	5.41	4.58	6.3	6.24
Capex per share	0.43	0.55	0.55	0.49	0.38	0.62	0.97	1.01	1.3	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	3.31%	3.94%	3.58%	3%	2.21%	2.96%	4.25%	4.36%	5.81%	—	—
Capex / operating cash flow	18.4%	19.8%	16.5%	15.3%	13.9%	12%	23.5%	19.9%	21.7%	—	—
Payout ratio	32.5%	24.9%	60.4%	19.2%	30.9%	19.5%	19.9%	21.4%	21.3%	21.6%	20%
Dividend yield	1.06%	0.78%	0.92%	0.87%	0.7%	0.49%	0.6%	0.87%	0.73%	0.68%	0.58%

Yield

0.58%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.255

ex-dividend Jun 30, 2026

Payout ratio

20%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jun 30, 2026	$0.255
Mar 31, 2026	$0.255
Jan 6, 2026	$0.255

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	$1.7B	$1.7B	$1.6B	$1.6B	$1.7B	$1.7B	$1.7B	$1.7B	$1.9B	$1.8B	$1.8B	$1.9B
YoY change	-8.71%	-5.58%	-8.39%	-5.62%	+0.77%	+1.39%	+6.04%	+10.1%	+9.41%	+6.96%	+10%	+8.06%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	2.3B	2.7B	2.2B	1.4B	1.4B	1.6B	1.1B	1.6B	1.3B	1.8B
Receivables	631M	724M	776M	930M	1B	1.2B	1.4B	1.3B	1.3B	1.5B
Inventory	533M	575M	638M	679M	720M	830M	1B	1B	972M	1B
Total current assets	3.6B	4.2B	3.8B	3.2B	3.4B	3.8B	3.8B	4.2B	4B	4.6B
Property, plant & equipment	-118M	-129M	-130M	-162M	-210M	-202M	-155M	-139M	-8M	-33M
Goodwill & intangibles	5.9B	5.9B	6.9B	9.4B	8.9B	9.9B	9.5B	8.9B	10B	9.8B
Total assets	7.8B	8.4B	8.5B	9.5B	9.6B	10.7B	10.5B	10.8B	11.8B	12.7B
Accounts payable	257M	305M	340M	354M	354M	446M	580M	418M	540M	570M
Short-term debt	—	210M	—	616M	75M	—	36M	—	45M	304M
Total current liabilities	945M	1.3B	1.2B	2.1B	1.5B	1.7B	1.9B	1.6B	1.9B	2.3B
Long-term debt	1.9B	1.8B	1.8B	1.8B	2.3B	2.7B	2.7B	2.7B	3.3B	3B
Total liabilities	3.5B	3.6B	4B	4.7B	4.8B	5.3B	5.2B	4.9B	5.9B	6B
Shareholders' equity	4.2B	4.8B	4.6B	4.7B	4.9B	5.4B	5.3B	5.8B	5.9B	6.7B
Total debt	1.9B	2B	1.8B	2.4B	2.4B	2.7B	2.8B	2.7B	3.4B	3.4B
Net debt	-385M	-667M	-448M	1B	918M	1.2B	1.7B	1.1B	2.1B	1.6B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Cash & short-term investments	1.6B	1.7B	1.7B	1.8B	1.3B	1.5B	1.5B	1.5B	1.8B	1.8B	1.8B	1.8B
Receivables	1.3B	1.3B	1B	983M	1.3B	1.1B	1.1B	1.1B	1.5B	1.5B	1.5B	1.5B
Inventory	1B	1B	1B	978M	972M	997M	991M	1B	1B	1.1B	1.1B	1.1B
Total current assets	4.2B	4.3B	4.2B	4.3B	4B	4.1B	4.2B	4.3B	4.6B	4.6B	4.8B	4.7B
Property, plant & equipment	-139M	—	—	—	-8M	—	—	—	-102M	—	—	—
Goodwill & intangibles	8.9B	8.8B	8.8B	8.7B	10B	9.9B	9.9B	9.9B	9.8B	9.8B	9.8B	11.9B
Total assets	10.8B	10.9B	10.9B	11B	11.8B	11.9B	12.2B	12.2B	12.7B	12.8B	13.1B	14B
Accounts payable	418M	488M	461M	497M	540M	547M	517M	530M	570M	602M	615M	608M
Short-term debt	—	—	420M	795M	45M	16M	146M	59M	304M	304M	304M	304M
Total current liabilities	1.6B	1.6B	2B	2.4B	1.9B	1.9B	2B	1.9B	2.3B	2.2B	2.3B	2.3B
Long-term debt	2.7B	2.6B	2.1B	2.1B	3.3B	3.3B	3.3B	3.4B	3B	3B	3.1B	3.6B
Total liabilities	4.9B	4.8B	4.6B	5.1B	5.9B	5.9B	6B	5.9B	6B	5.9B	5.9B	6.6B
Shareholders' equity	5.8B	6.2B	6.2B	5.9B	5.9B	6B	6.1B	6.4B	6.7B	6.9B	7.1B	7.4B
Total debt	2.7B	2.6B	2.6B	2.9B	3.4B	3.4B	3.5B	3.4B	3.4B	3.4B	3.4B	3.9B
Net debt	1.1B	807M	885M	1.2B	2.1B	1.9B	2B	1.9B	1.6B	1.6B	1.5B	2.2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	462M	684M	316M	1.1B	719M	1.2B	1.3B	1.2B	1.3B	1.3B
Depreciation & amortization	246M	212M	210M	238M	308M	321M	317M	271M	257M	288M
Stock-based compensation	58M	60M	70M	72M	83M	110M	125M	111M	129M	128M
Change in working capital	-40M	-200M	471M	-130M	-326M	-102M	-478M	-116M	83M	-131M
Operating cash flow	754M	889M	1.1B	1B	849M	1.6B	1.2B	1.5B	1.7B	1.6B
Capital expenditure	-139M	-176M	-176M	-155M	-118M	-187M	-291M	-298M	-378M	—
Investing cash flow	-238M	-304M	-705M	-1.6B	-147M	-749M	-338M	-310M	-1.3B	13M
Dividends paid	-150M	-170M	-191M	-206M	-222M	-236M	-250M	-265M	-274M	-282M
Share repurchases	-434M	-194M	-422M	-723M	-469M	-788M	-1.1B	-575M	-1.1B	-425M
Financing cash flow	-622M	-268M	-853M	-353M	-1.1B	-751M	-1.4B	-997M	-829M	-787M
Net change in cash	-106M	317M	-492M	-926M	-420M	64M	-532M	190M	-349M	785M
Free cash flow	654M	713M	910M	865M	802M	1.3B	1B	1.5B	1.4B	1.2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Net income	475M	348M	308M	282M	351M	318M	215M	336M	434M	305M	339M	362M
Depreciation & amortization	62M	62M	63M	63M	69M	72M	73M	72M	71M	67M	67M	66M
Stock-based compensation	14M	44M	31M	28M	26M	40M	30M	32M	26M	41M	32M	32M
Change in working capital	-48M	21M	-75M	66M	71M	2M	-136M	-82M	85M	-180M	-211M	18M
Operating cash flow	531M	480M	334M	454M	470M	432M	178M	362M	545M	268M	277M	519M
Capital expenditure	-84M	-90M	-103M	-92M	-93M	-97M	-114M	—	—	—	—	—
Investing cash flow	-40M	-95M	-109M	-100M	-954M	-94M	-114M	2M	3M	0	0	-952M
Dividends paid	-66M	-69M	-69M	-68M	-68M	-71M	-70M	-71M	-70M	-72M	-72M	-72M
Share repurchases	-80M	0	-230M	-585M	-335M	-90M	-165M	-85M	-85M	-152M	-65M	-78M
Financing cash flow	-203M	-274M	-300M	-279M	-1.2B	-210M	-117M	-248M	-212M	-253M	-145M	440M
Net change in cash	288M	111M	-75M	75M	-1.7B	128M	-53M	116M	336M	15M	132M	7M
Free cash flow	432M	395M	230M	360M	388M	334M	107M	259M	452M	175M	201M	439M

Agilent Technologies Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history